Determination of enantiomerization barriers of hypericin and pseudohypericin by dynamic high-performance liquid chromatography on immobilized polysaccharide-type chiral stationary phases and off-column racemization experiments

Chirality

Volumn 22, Issue 5, 2010, Pages 463-471

  Ciogli, Alessia ^a,b   Bicker, Wolfgang ^a   Lindner, Wolfgang ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Chiral stationary phase; Dynamic high performance liquid chromatography; Enantiomerization barrier; Hypericin; Immobilized polysaccharides; Protohypericin; Pseudohypericin; Racemization in solution

Indexed keywords

HYPERICIN; POLYSACCHARIDE; PSEUDOHYPERICIN;

ARTICLE; CHIRALITY; ENANTIOMER; ENANTIOSELECTIVITY; ENTHALPY; ENTROPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; PERYLENE; POLYSACCHARIDES; STEREOISOMERISM; TEICOPLANIN;

EID: 77950851526     PISSN: 08990042     EISSN: 1520636X     Source Type: Journal    
DOI: 10.1002/chir.20764     Document Type: Article

References (37)

1. Barnes J, Anderson LA, Phillipson JD. St John's wort (Hypericum per-foratum L.): a review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol 2001;53:583-600. (Pubitemid 32457809)
2. Macri BM, Stoian G, Flonta ML. Active compounds from Hyperici herba: traditional versus modern knowledge. In: Govil JN, Singh VK, Arunachalam C, editors. Recent progress in medicinal plants, Vol.14. Houston: Studium Press; 2006. p 339-355.
3. Falk H. From the photosensitizer hypericin to the photoreceptor sten-torin\the chemistry of phenantroperylene quinones. Angew Chem Int Ed Engl 1999;38:3117-3136. (Pubitemid 29533878)
4. Agostinis P, Vantieghem A, Merlevede W, de Witte PAM. Hypericin in cancer treatment: more light on the way. Int J Biochem Cell Biol 2002;34:221-241. (Pubitemid 34159138)
5. Kiesslich T, Krammer B, Plaetzer K. Cellular mechanisms and prospective applications of hypericin in photodynamic therapy. Curr Med Chem 2006;13:2189-2204. (Pubitemid 44132609)
6. Kubin A, Wierrani F, Burner U, Alth G, Gruenberger W. Hypericin\the facts about a controversial agent. Curr Pharm Des 2005;11:233-253.
7. Miskovsky P. Hypericin\a new antiviral and antitumor photosensi-tizer: mechanism of action and interaction with biological macromole-cules. Curr Drug Targets 2002;3:55-84. (Pubitemid 34296305)
8. Olivo M, Du HY, Bay BH. Hypericin lights up the way for the potential treatment of nasopharyngeal cancer by photodynamic therapy. Curr Clin Pharmacol 2006;1:217-222.
9. Saw CLL, Olivo M, Soo KC, Heng PWS. Use of hypericin in photody-namic applications. In: Govil JN, Singh VK, Arunachalam C, editors. Recent progress in medicinal plants, Vol.20. Houston: Studium Press; 2008. p 249-275.
10. Waser M, Falk H. Towards second generation hypericin based photosen-sitizers for photodynamic therapy. Curr Org Chem 2007;11:547-558. (Pubitemid 46621666)
11. Brockmann H, Kluge F, Muxfeldt H. Totalsynthese des Hypericins. Chem Ber 1957;90:2302-2318.
12. Brockmann H, Falkenhausen EH, Neeff R, Dorlars A, Budde G. Die konstitution des hypericins. Chem Ber 1951;84:865-887.
13. Brockmann H, Franssen U, Spitzner D, Augustiniak H. Zur isolierung und konstitution des pseudohypericins. Tetrahedron Lett 1974;15: 1991-1994.
14. Brockmann H, Sanne W. Zur kenntnis des hypericins und pseudo-hypericins. Chem Ber 1957;90:2480-2491.
15. Brockmann H, Sanne W. Zur biosynthese des hypericins. Naturwis-senschaften 1953;40:509-510.
16. Falk H, Meyer J, Oberreiter M. A convenient semisynthetic route to hypericin. Monatsh Chem 1993;124:339-341.
17. Skalkos D, Tatsis E, Gerothanassis IP, Troganis A. Towards a consensus structure of hypericin in solution: direct evidence for a single tau-tomer and different ionization states in protic and nonprotic solvents by the use of variable temperature gradient 1H NMR. Tetrahedron 2002;58:4925-4929. (Pubitemid 34628849)
18. Etzlstorfer C, Falk H, Müller N, Schmitzberger W, Wagner UG. Tau-tomerism and stereochemistry of hypericin: force field, NMR, and X-ray crystallographic investigations. Monatsh Chem 1993;124:751-761.
19. Petrich JW, Gordon MS, Cagle M. Structure and energetics of ground-state hypericin: comparison of experiment and theory. J Phys Chem A 1998;102:1647-1651. (Pubitemid 128578225)
20. Kapinus EI, Falk H, Tran HTN. Spectroscopic investigation of the molecular structure of hypericin and its salts. Monatsh Chem 1999;130:623-635.
21. Mylrajan M, Hildebrandt P, Mazur Y. Vibrational spectroscopy of hy-pericin, its sodium salt and pyridinium complex. J Mol Struct 1997;407:5-10. (Pubitemid 27243003)
22. Wen J, Chowdhury P, Fulton DB, Datta A, Das K, Andreotti AH, Pet-rich JW. Does solvent influence the ground-state tautomeric population of hypericin? Photochem Photobiol 2003;77:5-9.
23. Freeman D, Frolow F, Kapinus A, Lavie B, Lavie G, Meruelo D, Mazur Y. Acidic propertiesof hypericin and its octahydroxy analogue inthe ground and excited states. J Chem Soc Chem Comm 1994:891-892. (Pubitemid 24119308)
24. Altmann R, Etzlstorfer C, Falk H. Concerning the enantiomerization barrier of hypericin. Monatsh Chem 1997;128:361-370. (Pubitemid 127054998)
25. Tran HTN, Falk H. Concerning the chiral discrimination and helix inversion barrier in hypericinates and hypericin derivatives. Monatsh Chem 2002;133:1231-1237.
26. D'Acquarica I, Gasparrini F, Pierini M, Villani C, Zappia G. Dynamic HPLC on chiral stationary phases: a powerful tool for the investigation of stereomutation processes. J Sep Sci 2006;29:1508-1516. (Pubitemid 44122018)
27. Krupcik J, Oswald P, Majek P, Sandra P, Armstrong DW. Determination of the interconversion energy barrier of enantiomers by separation methods. J Chromatogr A 2003;1000:779-800. (Pubitemid 36638485)
28. Trapp O, Schoetz G, Schurig V. Determination of enantiomerization barriers by dynamic and stopped-flow chromatographic methods. Chirality 2001;13:403-414. (Pubitemid 32729794)
29. Sanders L, Halder M, Xiao TL, Ding J, Armstrong DW, Petrich JW. The separation of hypericin's enantiomers and their photophysics in chiral environments. Photochem Photobiol 2005;81:183-186. (Pubitemid 40327577)
30. Gasparrini F, Pierini M, Villani C, De Maria P, Fontana A, Ballini R. Enantiomerization study of some a-nitroketones by dynamic high-resolution gas chromatography. J Org Chem 2003;68:3173-3177. (Pubitemid 36443903)
31. Reist M, Testa B, Carrupt PA, Jung M, Schurig V. Racemization, enantiomerization, diastereomerization, and epimerization: their meaning and pharmacological significance. Chirality 1995;7:396-400.
32. Ikai T, Yamamoto C, Kamigaito M, Okamoto Y. Immobilized-type chi-ral packing materials for HPLC based on polysaccharide derivatives. J Chromatogr B 2008;875:2-11.
33. Chen X, Yamamoto C, Okamoto Y. Polysaccharide derivatives as useful chiral stationary phases in high-performance liquid chromatogra-phy. Pure Appl Chem 2007;79:1561-1573.
34. Zhang T, Nguyen D, Franco P. Enantiomer resolution screening strategy using multiple immobilised polysaccharide-based chiral stationary phases. J Chromatogr A 2008;1191:214-222.
35. Franco P, Zhang T. Common approaches for efficient method development with immobilised polysaccharide-derived chiral stationary phases. J Chromatogr B 2008;875:48-56.
36. Altmann R, Etzlstorfer C, Falk H. Chiroptical properties and absolute configurations of the hypericin chromophore propeller enantiomers. Monatsh Chem 1997;128:785-793. (Pubitemid 127498337)
37. Falk H, Meyer J. On the homo-and heteroassociation of hypericin. Monatsh Chem 1994;125:753-762.